Prescription medication · Recombinant Human Growth Hormone
growth hormone
Also sold as Norditropin, Genotropin. This medicine may help with a tendency to catch colds or the flu.
Data updated 2026-05-15
- $1715.73
- Brand price (NADAC)
growth hormone (Norditropin) is a prescription Recombinant Human Growth Hormone. This medicine may help with a tendency to catch colds or the flu.
This medicine is a growth hormone. It may help your body's defenses and relieve some symptoms.
Verify with FDA → · CMS NADAC pricing →
Drug Pricing (NADAC)
Brand Price
$1715.73/unit
Generic Available
No
Pricing data from NADAC (CMS), effective December 18, 2024. Compare all drug costs →
What it does
This medicine may help with a tendency to catch colds or the flu.
Common side effects
No common side effects listed.
Key warnings
The FDA has not evaluated these claims.
The sections below are summarized in plain English from growth hormone's FDA-approved prescribing information. They describe what the official label says, and are not personal medical advice.
How It Works
This medicine is a recombinant human growth hormone. It works by supplementing your body's natural growth hormone.
How to Take It
Adults only should use this medicine. Spray it two times under your tongue. Do this three times each day. One bottle should last about a month.
This is a plain-language summary of growth hormone's FDA labeling, not individualized dosing advice. Ask a pharmacist or prescriber before changing how you take this medication.
Missed Dose
If you miss a dose, just take your next dose as scheduled. Do not double your dose.
This is a plain-language summary of growth hormone's FDA labeling, not individualized advice. Ask a pharmacist or prescriber what to do about your specific missed dose.
Storage
Store this medicine as directed on the package.
Serious Warnings
The FDA has not evaluated these claims.
Common Questions
How long will it take to see results?
Can children use this medicine?
How many times a day should I use the spray?
How long will one bottle last?
What if I don't see any improvement?
Is this medicine FDA approved?
What should I do if I experience side effects?
Can I take this with other medications?
What do I do if I miss a dose?
How should I store this medicine?
What drug class is growth hormone?
Related Medications in Recombinant Human Growth Hormone
Other drugs grouped near growth hormone - same-class peers and common alternatives.
abiraterone
Zytiga
Abiraterone (Zytiga) is a medicine used with prednisone to treat prostate cancer that has spread.
Compare with growth hormone →
anastrozole
Arimidex
Anastrozole is a medicine used to treat breast cancer in women after menopause.
Compare with growth hormone →
bazedoxifene/conjugated estrogens
Duavee
Duavee is a combination medicine containing estrogen and a drug that blocks estrogen in some parts of the body.
Compare with growth hormone →
cabergoline
Dostinex
Cabergoline is a medicine that helps lower the amount of prolactin in your body.
Compare with growth hormone →
clomiphene
Clomid, Serophene
Clomiphene citrate is a medicine that helps women ovulate.
Compare with growth hormone →
Medication Guides
Understanding Drug Interactions
How CYP450 enzymes, inhibitors, and inducers affect your medications
Generic vs Brand Name Drugs
FDA requirements, cost savings, and when the difference matters
Narrow Therapeutic Index Drugs
Why some drugs demand precise dosing and monitoring
Common Drug Interactions
Dangerous medication combinations and how to protect yourself
Save on growth hormone
Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.
Disclosure: This link may earn us a commission at no extra cost to you. See our terms.
What the FDA Data Shows for growth hormone
The FDA label for growth hormone (sold under brand names such as Norditropin, Genotropin) classifies it as a prescription-only medication in the Recombinant Human Growth Hormone class. This medicine may help with a tendency to catch colds or the flu. Labeling covers dosing, contraindications, and monitoring requirements derived from clinical trials.
Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. Voluntary reports accumulate over the lifetime of a drug and reflect wide-ranging clinical use. Interaction data is drawn directly from FDA-approved prescribing information. NADAC pricing from CMS.
Report counts do not establish causation, a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information further shape supply and switching decisions. This page summarizes public FDA data for educational purposes only and is not a substitute for professional medical advice, always consult a licensed healthcare provider before starting, stopping, or changing any medication.
Data Sources
Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC).
FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. Always consult a healthcare professional before making medication decisions.
Last updated: January 31, 2025
Read our methodology - how this data is sourced, computed, and verified.
Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled and last refreshed May 2026. See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
All federal data sources used on this page
- FDA Orange Book - approved drug products with therapeutic equivalence. accessdata.fda.gov/cder/ob
- FDA DailyMed - NIH-hosted drug labeling for FDA-approved meds. dailymed.nlm.nih.gov
- FDA Adverse Event Reporting System (FAERS) - post-marketing safety surveillance. fda.gov/drugs/faers
- NLM RxNorm - standardized clinical drug nomenclature. nlm.nih.gov/research/umls/rxnorm
- CMS Medicare Part B Drug Average Sales Price Files - federal drug pricing data. cms.gov/medicare/part-b-drugs/asp
- FDA Drug Shortages Database - current and resolved drug shortage tracking. accessdata.fda.gov/drugshortages